Biotalys NV

Results of the Ordinary Shareholders’ Meeting

22 أبريل 2025 10:59:59 بحسب Nasdaq GlobeNewswire

Biotalys to Appoint Toni Bucci to its Board of Directors

25 مارس 2025 01:00:00 بحسب Nasdaq GlobeNewswire

Invitation to the ordinary general shareholders meeting

21 مارس 2025 01:30:00 بحسب Nasdaq GlobeNewswire

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights

19 مارس 2025 01:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide

11 مارس 2025 01:00:00 بحسب Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

27 يناير 2025 11:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Provides Regulatory Review Update on EVOCA

14 يناير 2025 00:00:00 بحسب Nasdaq GlobeNewswire

Publication of transparency notifications

23 أكتوبر 2024 11:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

17 أكتوبر 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys announces Closing of Private Placement

16 أكتوبر 2024 11:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

14 أكتوبر 2024 01:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Granted Patents for EVOCA in Both Europe and the United States

17 سبتمبر 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

02 سبتمبر 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights

22 أغسطس 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Named Sustainable Crop Protection Company of the Year

21 أغسطس 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Notice of Half Year 2024 Results and Business Highlights

05 أغسطس 2024 11:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Starts Field Trials for Second Biofungicide

02 مايو 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Biotalys Appoints Laura J. Meyer to Board of Directors

30 أبريل 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Results of the Ordinary and Extraordinary Shareholders’ Meeting

23 أبريل 2024 11:00:00 بحسب Nasdaq GlobeNewswire

Results of the Special Shareholders’ Meeting

29 مارس 2024 12:00:00 بحسب Nasdaq GlobeNewswire